News

Sotagliflozin Shines: Renal Benefits Unveiled at ASN 2024

Sotagliflozin Shines: Renal Benefits Unveiled at ASN 2024

Understanding Sotagliflozin and Its Impact

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor developed by Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), has emerged at the forefront of research focusing on renal protection for patients dealing with diabetic kidney disease (DKD). This was highlighted in a recent analysis derived from the Phase 3 SCORED clinical trial, which was unveiled at Kidney Week 2024, an influential annual gathering for nephrology professionals.

Insights from the Phase 3 SCORED Trial

The SCORED trial has previously substantiated that sotagliflozin considerably lowers the risk associated with kidney and cardiorenal composite endpoints among individuals diagnosed with type 2 diabetes (T2D) and DKD. This latest post hoc analysis aims to delve deeper into the effects of sotagliflozin compared to a placebo, specifically examining the Estimated Glomerular Filtration Rate (eGFR) slope and how factors like baseline kidney function and glycemic control play a role.

Investigative Presentation Details

The findings from the analysis are set to be shared during a moderated poster session at ASN Kidney Week 2024. The presentation titled “Effect of sotagliflozin on eGFR slope by baseline kidney function and glycemic control” will be delivered by Dr. Vikas S. Sridhar from the University of Toronto.

Findings and Their Significance

The investigation encompassed a significant cohort of 10,574 participants. The results revealed a placebo-adjusted acute decline in eGFR of -2.59 ml/min/1.73m²/year, denoting a considerable impact from the placebo group (95% CI -2.88, -2.30; p<0.0001). Interestingly, while the total placebo-adjusted slope remained -0.08 ml/min/1.73m²/year, sotagliflozin showcased a pronounced advantage in chronic slope assessments, particularly with escalating baseline albuminuria (P-interaction=0.023).

The Voice of Research Leadership

As Craig Granowitz, M.D., Ph.D., the Senior Vice President and Chief Medical Officer at Lexicon, mentioned, “Researchers observed positive renal protection with sotagliflozin across a spectrum of baseline kidney function and glycemic control.” This underscores the substantial role sotagliflozin can play in the management of diabetic kidney disease, further validating its clinical efficacy.

About Sotagliflozin

Sotagliflozin showcases a pioneering approach to addressing renal health. It acts as an oral inhibitor targeting both SGLT1 and SGLT2 proteins involved in glucose regulation. This mechanism is crucial as SGLT2 is responsible for the reabsorption of glucose and sodium by the kidneys, while SGLT1 manages glucose and sodium absorption in the gastrointestinal tract. Clinical evaluations of sotagliflozin encompass varied patient populations, including those with heart failure, diabetes, and chronic kidney disease, with approximately 20,000 individuals having participated in clinical studies.

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals is steadfast in its mission to innovate treatments that significantly improve patient outcomes. Utilizing its Genome5000™ program, the organization has explored almost 5,000 genes, pinpointing over 100 potential therapeutic protein targets across numerous diseases. Through this strategic focus on protein targeting, Lexicon is advancing the discovery of safe and effective medications. Among its commercial successes is INPEFA® (sotagliflozin), alongside an array of promising candidates in discovery phases addressing neuropathic pain, diabetes, and various other conditions.

Frequently Asked Questions

What is the primary focus of the recent analysis by Lexicon Pharmaceuticals?

The recent analysis centers on demonstrating the renal protective benefits of sotagliflozin for patients with diabetic kidney disease.

What was the size of the participant cohort in the SCORED trial?

The SCORED trial included a comprehensive cohort of 10,574 participants.

Who presented the findings at ASN Kidney Week 2024?

The findings were presented by Dr. Vikas S. Sridhar, affiliated with the University of Toronto.

How does sotagliflozin work?

Sotagliflozin functions as an oral inhibitor targeting SGLT1 and SGLT2 proteins, which are integral to regulating glucose and sodium reabsorption in both the kidneys and the gastrointestinal tract.

What are Lexicon Pharmaceuticals' future goals?

Lexicon aims to develop innovative medicines addressing various health conditions, leveraging their genomics platform for therapeutic discoveries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mobile Core's Cost Crunch Favors Telecom's Big Three

Updated Category News Views 34

Server bills have finally crashed the party in mobile core, and nobody should pretend that is a minor inconvenience. Dell'Oro Group's 3Q 2026 read is blunt: Mobile Core Network revenue growth was lackluster because 5G spending came in below expectations, while higher server costs pushed operators to reshuffle priorities, postpone projects, and keep 4G core gear alive...

Continue Reading
Ductless Mini-Splits Put HVAC Efficiency Into Focus

Updated Category News Views 55

Ductless mini-splits have slipped from contractor jargon into a serious conversation about how homes and smaller buildings are heated and cooled. That is the worthwhile backdrop for a HelloNation article featuring HVAC expert Natasha Adams. The source notes are lean—really lean—and do not spell out her specific guidance, product comparisons, efficiency figures,...

Continue Reading
PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 183

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 86

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Nvidia Lawsuit Allegations Put Disclosure Risk in Focus

Updated Category News Views 67

A lawsuit notice can turn a roaring chip story sour in a hurry, and this one deserves a cold, careful read rather than the usual internet stampede. DJS Law Group says it has filed a securities class action against NVIDIA, alleging that the company made materially false and misleading statements during a stated class period running from October 9, 2025 through November 8,...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 147

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 0

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 65

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Hydron’s Bailey Test Puts RNG Cost Claims to Real Work

Updated Category News Views 55

Landfill gas is messy stuff, which is exactly why Hydron Energy’s Bailey Landfill demonstration in Chilliwack deserves more attention than another clean-energy press release. The British Columbia company is putting its INTRUPTor™ gas-separation system into an operating environment alongside FortisBC and the City of Chilliwack, where the machinery has to deal with real...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 51

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading

Top 5 Most Recently Viewed Articles

Wesdome Gold Mines Pursues Significant Share Repurchase Plan

Updated Category News Views 220

Wesdome Gold Mines Initiates Share Buyback Program Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) is excited to unveil its plan for a Normal Course Issuer Bid (NCIB), which has just received approval from its board of directors and is pending final consent from the Toronto Stock Exchange (TSX). This strategic initiative allows the company to buy back a substantial 2% of...

Continue Reading
Zillow Faces August Class Action Deadline: Investor Alert

Updated Category News Views 51

Investor Tensions Rise Ahead of Zillow's Legal Deadline August 10, 2026—mark it down. That's your last call to jump into the fray with the class action suit against Zillow Group, Inc. (NASDAQ: ZG, Z), should you have skin in the game. We're talking investors who bought into Zillow from February 11, 2025, through May 7, 2026. Yeah, 'investor alert' might as well be...

Continue Reading
Explore Opportunities in the 2025 Global Omics Sciences Contest

Updated Category News Views 214

Unveiling the 2025 Mammoth International Contest on Omics Sciences Guided by esteemed organizations like UNESCO, the 2025 Mammoth International Contest on Omics Sciences offers young scientists an incredible platform to showcase their talents and innovative ideas. This initiative is proudly co-organized by BGI Research and the Jinze Charitable Foundation, unveiling a new...

Continue Reading
Navigating Disagreements: Jeff Bezos' Unique Leadership Style

Updated Category News Views 544

Embracing Different Perspectives: Jeff Bezos' Approach In a recent discussion, Jeff Bezos, the founder of Amazon.com, Inc. (NASDAQ: AMZN), reflected on his distinctive methodology for making decisions quickly and effectively. He believes that fostering an environment of trust and open dialogue is essential for overcoming disagreements. The Philosophy of Disagree and...

Continue Reading
Exploring Philanthropy's Impact on the U.S.-Mexico Border

Updated Category News Views 273

Unveiling Border Briefs in San Diego Recently, the U.S.-Mexico Border Philanthropy Partnership (BPP) introduced the Border Briefs series during an impactful event named Voices and Visions from the Border: A Funder Dialogue. This gathering was held at the San Diego Central Library, aiming to highlight the dynamic role that philanthropy plays in addressing challenges and...

Continue Reading